Estimate Recalculated Sep 9, 2024 12:20AM EST
Robb Knie does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Hoth Therapeutics, Inc., FoxWayne Enterprises Acquisition Corp., and Inventergy Global, Inc..
Robb Knie's CIK is 0001609695
2022 was Robb Knie's most active year for acquiring shares with 2 total transactions. Robb Knie's most active month to acquire stocks was the month of August. 2024 saw Robb Knie paying a total of $16,750.00 for 250,000 shares, this is the most they've acquired in one year.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!